Cleveland biolabs inc (CBLI)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
Revenues:
Grants and contracts

156

177

269

276

197

-

283

391

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Grants and contracts

-

-

-

-

-

-

-

-

227

870

296

206

574

989

1,141

575

812

1,269

501

329

607

1,390

415

562

1,334

3,871

1,635

1,613

1,367

2,161

219

258

931

1,945

3,801

569

2,473

-

-

Operating expenses:
Grants and contracts

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,189

4,210

Sales Revenue, Net, Total

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4,210

Research and development

218

281

262

599

513

534

839

908

1,336

1,523

919

1,188

1,416

2,157

1,104

1,292

1,941

1,896

2,052

1,583

1,610

2,821

2,068

2,324

2,439

4,616

4,205

5,373

5,331

5,581

4,841

6,093

5,985

5,347

6,522

5,209

5,708

3,083

4,170

General and administrative

382

368

525

448

474

329

711

550

727

559

575

588

777

666

750

777

1,183

1,184

1,266

1,597

2,307

2,020

1,785

2,250

2,413

2,251

3,286

3,016

3,483

-

3,219

3,326

-

-

-

-

1,877

-

-

General and administrative

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,427

-

4,239

1,987

-

1,073

2,661

Total operating expenses

600

649

788

1,048

988

863

1,551

1,459

2,063

2,083

1,494

1,776

2,194

2,824

1,855

2,069

3,124

3,080

3,318

3,180

3,918

4,842

3,853

4,574

4,853

6,867

7,492

8,389

8,814

7,722

8,061

9,419

8,413

8,350

10,762

7,196

7,586

4,157

6,831

Loss from operations

-444

-471

-518

-771

-790

-627

-1,267

-1,068

-1,836

-1,213

-1,197

-1,570

-1,619

-1,835

-714

-1,494

-2,312

-1,811

-2,817

-2,850

-3,311

-3,451

-3,438

-4,012

-3,519

-2,996

-5,856

-6,776

-7,447

-5,561

-7,841

-9,161

-7,481

-6,404

-6,961

-6,627

-5,112

-967

-2,620

Other income (expense):
Other income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-50

Other expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Change in value of warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-714

-

-

Interest and other income (expense)

2

-714

14

25

-7

16

16

23

69

30

67

50

49

-82

42

121

181

261

-233

-81

-46

-78

-68

-623

-317

-180

97

47

79

-

228

70

-

-

-

-

-633

40

-

Interest and other income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

55

-

52

116

49

49

-7

Foreign exchange gain (loss)

0

-0

0

-0

-0

0

1

1

-0

-0

-0

-4

-8

271

10

33

47

-318

-212

65

-43

-705

-271

92

-151

-21

-15

46

28

-35

-278

641

-692

-

36

-174

32

-

-

Gain on investment provision

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-32

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in value of warrant liability

160

-18

-36

-112

94

-162

-121

-170

-508

14

166

4,124

121

-399

-1,834

547

-1,412

-1,260

-46

1,480

49

-998

836

-412

-2,087

-2,353

-1,163

-2,795

3,447

-

4,423

-2,543

-

-

-

-

-

-

-

Equity in loss of Incuron, LLC

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-114

-247

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in value of warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,719

-

-3,993

-17,815

-

-

-

Change in value of warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

6,408

33

Total other income (expense)

-157

-696

51

138

-103

179

139

195

577

15

-98

-4,077

-80

661

1,854

-392

1,641

142

-398

-1,610

-387

14,135

-1,176

-119

1,617

2,151

1,245

2,890

-3,339

7,768

-4,474

3,254

1,082

-

4,082

17,757

-

-6,317

-91

Net loss

-601

-1,168

-467

-633

-893

-448

-1,128

-872

-1,258

-1,198

-1,296

-5,648

-1,700

-1,173

1,140

-1,886

-670

-1,668

-3,215

-4,461

-3,698

10,683

-4,615

-4,131

-1,901

-844

-4,610

-3,886

-10,787

2,206

-12,315

-5,906

-6,398

-7,735

-2,878

11,130

-5,745

-7,285

-2,528

Net loss

-601

-1,168

-467

-633

-893

-448

-1,128

-872

-1,258

-1,198

-1,296

-5,648

-1,700

-

1,140

-1,886

-

-

-

-

-

-

-

-

-

-

-4,610

-3,886

-10,787

-

-12,315

-5,906

-6,398

-7,735

-2,878

11,130

-5,745

-7,285

-2,528

Net loss attributable to noncontrolling interests

-13

6

-17

-16

-20

-16

-23

-21

-33

-29

-35

-35

-36

57

2

11

-2

-246

-95

-17

-48

-587

-519

-170

-315

-1,519

519

-844

-1,022

-2,926

-1,437

-828

1,011

-918

187

-238

-246

-82

-89

Net loss attributable to Cleveland BioLabs, Inc.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-3,961

-1,585

-365

-4,091

-3,042

-9,764

-

-10,877

-5,078

-

-

-

-

-

-

-

Net loss attributable to Cleveland BioLabs, Inc.

-588

-1,175

-449

-616

-872

-431

-1,104

-851

-1,224

-

-1,260

-5,612

-1,663

-

1,138

-1,897

-667

-

-3,120

-4,444

-3,650

-

-4,096

-

-

-

-

-

-

-

-

-

-5,387

-

-2,691

11,368

-5,499

-7,203

-2,439

Net loss attributable to common stockholders per share of common stock, basic and diluted (in dollars per share)

-0.05

-0.11

-0.04

-0.05

-0.08

-0.03

-0.10

-0.08

-0.11

-0.11

-0.11

-0.50

-0.15

-0.11

0.10

-0.17

-0.06

0.78

-0.31

-1.12

-1.14

4.19

-1.43

-1.53

-0.63

-7.29

-0.09

-0.07

-0.22

-9.16

-0.30

-0.14

-0.15

-

-

-

-0.19

-

-

Weighted average number of shares used in calculating net loss per share, basic and diluted (in shares)

11,353

11,298

11,298

11,298

11,298

11,298

11,298

11,298

11,280

11,284

11,279

11,218

10,987

10,987

10,987

10,987

10,987

10,887

10,168

3,979

3,206

2,863

2,855

2,594

2,498

-125,835

45,061

44,948

44,826

-99,804

35,879

35,745

35,657

-

-

-

-

-

-

Net income (loss) available to common stockholders per share of common stock, basic (in Dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.08

0.38

-

-0.27

-0.09

Net loss available to common stockholders per share of common stock, basic and diluted (in Dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.08

0.30

-

-0.27

-0.09

Weighted average number of shares used in calculating net income (loss) per share, basic (in Shares)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

35,447

30,033

-

26,984

26,734

Weighted average number of shares used in calculating net loss per share, basic and diluted (in Shares)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

35,447

37,588

-

26,984

26,734

Weighted average number of shares used in calculating net loss per share, basic and diluted (in Shares)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

29,110

-

-